Dual Checkpoint Blockade of CTLA-4 and PD-1 Overcomes Low–Tumour Mutational Burden Resistance

Clinical Oncology 2026

View at publisher

Authors: Ming Zheng

DOI: 10.1016/j.clon.2026.104061

Cited by: 1

References: 5

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Diabetes and associated disorders T-cell and B-cell Immunology

References 5